Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
Prostate Cancer - Medicare Access (Medicare patients only)
Status
ClosedThis fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Fund Type
CopayPremium (Medicare Part B only)
Maximum Award Level
Pharmacy Card Fund
YesMinimum CopayReimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium
Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high
cost of living areas)
Treatments Covered
- Abiraterone Acetate
- Akeega
- Camcevi
- Casodex
- Cisplatin
- Cortef
- Dexamethasone
- Diethylstilbestrol
- Docetaxel
- Duavee
- Eligard
- Emcyt
- Erleada
- Estradiol
- Estrone
- Ethinyl Estradiol
- Etopophos
- Extina
- Fensolvi
- Firmagon
- Flutamide
- Fosamax
- Hydrocortisone
- Iodine-125 (no-otc)
- Jevtana
- Ketodan
- Keytruda
- Leuprolide Acetate
- Lupron
- Lupron Depot
- Lynparza
- Medrol
- Menest
- Mitoxantrone Hydrochloride
- Nilandron
- Nizoral
- Nizoral A-d
- Nubeqa
- Orgovyx
- Paraplatin
- Pluvicto
- Prednisone
- Premarin
- Prolia
- Provenge
- Rayos
- Rubraca
- Sodium Fluoride
- Supprelin La
- Talzenna
- Taxotere
- Tecentriq
- Trelstar
- Vantas
- Xgeva
- Xofigo
- Xolegel
- Xtandi
- Yonsa
- Zoladex
- Zoledronic Acid (non Otc)
- Zometa
- Zytiga
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of prostate cancer.
Grant Utilization
HealthWell estimates that patients use an average of $4,330 during their 12-month grant period for this disease area.
Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
-
This is a Medicare Access Fund. In order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Prostate Cancer
Prostate cancer begins when cells in the prostate gland start to grow out of control. Some prostate cancers grow and spread quickly, but most grow slowly. Almost all prostate cancers are adenocarcinomas, which develop from the gland cells. Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. In 2020, the ACS estimates approximately 192,000 new prostate cancer cases will be diagnosed and over 33,000 deaths will occur as a result of the disease. Approximately 1 in 9 men will be diagnosed with prostate cancer in their lifetime. Prostate cancer is more likely to develop in older men and in African-American men. About 6 cases in 10 are diagnosed in men who are 65 or older, and it is rare in men under 40. The average age at diagnosis is about 66. Source: American Cancer Society (ACS)
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.
